MYCENAX BIOTECH INC. financial statements, including revenue, expenses, profit, and loss

The total revenue of 4726 for the last quarter is 209.13 M TWD, and it's 4.25% higher compared to the previous quarter. The net income of Q3 24 is -146.61 M TWD.